Ezlopitant

CAS No. 147116-64-1

Ezlopitant( —— )

Catalog No. M36168 CAS No. 147116-64-1

Ezlopitant (CJ-11974) is a small molecule neurokinin-1-receptor (NK1) antagonist used to treat nausea, vomiting and pain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 129 Get Quote
5MG 200 Get Quote
10MG 295 Get Quote
25MG 539 Get Quote
50MG 718 Get Quote
100MG 981 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ezlopitant
  • Note
    Research use only, not for human use.
  • Brief Description
    Ezlopitant (CJ-11974) is a small molecule neurokinin-1-receptor (NK1) antagonist used to treat nausea, vomiting and pain.
  • Description
    Ezlopitant (CJ-11974) is a small molecule neurokinin-1-receptor (NK1) antagonist used to treat nausea, vomiting and pain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Neurokinin Receptor
  • Recptor
    Neurokinin receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    147116-64-1
  • Formula Weight
    454.65
  • Molecular Formula
    C31H38N2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C([C@H]1[C@@H](NCC2=C(OC)C=CC(C(C)C)=C2)C3CCN1CC3)(C4=CC=CC=C4)C5=CC=CC=C5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Hemokinin 1 (mouse)

    Hemokinin 1 (mouse) is a selective excitogen 1 receptor agonist with a Ki value of 0.175 nM for the human NK1 receptor and 560 nM for the human NK2 receptor.

  • Fosaprepitant dimegl...

    Fosaprepitant dimeglumine(MK-0517) is a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.

  • QWF

    Tripeptide substance P (SP) antagonist (IC50 = 90 μM). Also inhibits binding of SP to Mas-related GPCR (MRGPR) X2. Inhibits SP-induced IgE-independent degranulation of mast cells in vitro. Inhibits compound 48/80-induced MRGPRX2 activation and scratching in mice in vivo.